Omega Fund Management as of Sept. 30, 2023
Portfolio Holdings for Omega Fund Management
Omega Fund Management holds 12 positions in its portfolio as reported in the September 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Replimune Group Common Stock (REPL) | 47.2 | $51M | 3.0M | 17.11 | |
| Nuvation Bio Common Stock Class A (NUVB) | 18.6 | $20M | 15M | 1.34 | |
| Ikena Oncology Common Stock (IKNA) | 8.9 | $9.7M | 2.2M | 4.33 | |
| Morphic Holding Common Stock (MORF) | 6.5 | $7.1M | 310k | 22.91 | |
| Kronos Bio Common Stock (KRON) | 4.6 | $5.0M | 3.8M | 1.30 | |
| Spruce Biosciences Common Stock (SPRB) | 4.5 | $4.9M | 2.2M | 2.26 | |
| Sana Biotechnology Common Stock (SANA) | 3.0 | $3.3M | 844k | 3.87 | |
| Immunic Common Stock (IMUX) | 2.4 | $2.6M | 1.8M | 1.47 | |
| Theseus Pharmaceuticals Common Stock | 1.8 | $1.9M | 712k | 2.69 | |
| Alpine Immune Sciences Common Stock | 1.6 | $1.8M | 154k | 11.45 | |
| Syros Pharmaceuticals Common Stock (SYRS) | 0.9 | $993k | 251k | 3.95 | |
| Senti Biosciences Common Stock (SNTI) | 0.1 | $81k | 196k | 0.41 |
